Potential relationship of dyslipidemia with dietary patterns in oral lichen planus patients-A case-control study

Potential implication of serum lipid levels as predictive indicators for monitoring oral lichen planus

Compelling evidence indicates that dyslipidemia is positively associated with oral lichen planus (OLP). The types and magnitude of lipid metabolism disturbance in peripheral blood of OLP patients have been investigated in different studies. Yet, consensus on how these different lipid components varied in levels for the development of OLP lesions has not been reached so far. Herein, a total of 8 eligible studies were recognized, which enrolled 533 cases of OLP and 499 healthy controls. The analysis showed that the average total triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) levels were considerably higher, and high-density lipoprotein cholesterol (HDL-C) levels were significantly lower in OLP patients compared to healthy controls. Collectively, the lipid profile panel maybe serve as the potential predictive indicator for screening OLP.

Metabolic syndrome in patients with lichen planus: A case-control study

Background

Lichen Planus (LP) is a chronic dermatosis affecting the skin and mucous membranes. Chronic inflammation and oxidative stress in patients with LP is a trigger predisposing to Metabolic Syndrome.

Objectives

To study the association of Metabolic Syndrome in patients with LP.

Materials and Methods

A hospital-based prospective case-control study was conducted from April 2021 to January 2023 including 75 histopathologically confirmed patients with LP and 82 age and sex-matched controls according to the inclusion and exclusion criteria. Metabolic Syndrome was diagnosed using Modified National Cholesterol Education Programme Adult Treatment Panel III criteria. Statistical analysis of the data was performed using Statistical Package for the Social Sciences software, version 26. The chi-square test was used for data analysis.

Results

The majority (30.6%) of the patients belonged to the age group 31-40 years. The mean age of patients with LP was 46.13 ± 14.9 years. Female predominance (69.3%) was observed in our study. Patients with classic LP (54.6%) were predominantly observed. Metabolic Syndrome was significantly prevalent in LP patients than in controls (32% vs. 13.4%, p = 0.005, OR 3.037) and was significantly associated with morphology (only oral mucosal involvement, 61.5%, p 0.027, OR 3.9), severity (severe LP, 58.6%, p < 0.001, OR 7.79), and duration of the disease (≥6 months, 55.5%, p 0.001, OR 5.42). 71% of Metabolic Syndrome was observed in females (p 0.847). Among patients with metabolic syndrome, the majority belonged to the age group between 31 and 40 years (37.5%, p 0.378). Systolic and Diastolic Blood Pressure values (≥130/85 mm of Hg), Serum Triglycerides (≥150 mg/dl), and Low-Density Lipoprotein (>130 mg/dl) were significantly elevated, and High-Density Lipoprotein (<40 mg/dl) was significantly low in LP than in controls (p < 0.05).

Conclusion

The study showed a significant association of Metabolic Syndrome in patients with LP. Thus, patients with LP need to be screened to avoid complications associated with Metabolic Syndrome that is, Diabetes Mellitus, Cardiovascular Disease, colorectal cancer, and stroke.

Possible interplay of diabetes mellitus and thyroid diseases in oral lichen planus: A pooled prevalence analysis

The existence of a comorbidity between diabetes mellitus (DM) as well as between thyroid diseases (TD) and oral lichen planus (OLP), respectively, was substantially demonstrated. However, there is not enough attention to the concurrent status of both TD and DM in OLP patients. Herein, this short communication aimed to compare 1) the prevalence of DM when TD was concurrently investigated and that of DM when TD status was ignored; 2) the prevalence of TD when DM was concurrently investigated and that of TD when DM status was ignored in the studies. The pooled prevalence (9.86 %; 95 % confidence intervals [CI], 9.22-10.53 %) of DM when TD was concurrently investigated was significantly higher than that (8.13 %; 95%CI, 8.03-9.12 %) when TD status was not investigated in OLP patients. The pooled prevalence (12.48 %; 95%CI, 11.77-13.22 %) of TD when DM was concurrently investigated was significantly higher than that (10.45 %; 95%CI, 9.52-11.46 %) when DM status was not investigated in OLP patients. Thus, it is logical to presume for the first time that there is possible interplay of DM and TD in OLP occurrence. TD and DM should serve as important confounding factors each other in clinical investigation on OLP and associated comorbidities.